-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Asthma -X- _ O
is -X- _ O
a -X- _ O
major -X- _ O
public -X- _ O
health -X- _ O
problem -X- _ O
with -X- _ O
a -X- _ O
huge -X- _ O
social -X- _ O
and -X- _ O
economic -X- _ O
burden -X- _ O
affecting -X- _ O
300 -X- _ O
million -X- _ O
people -X- _ O
worldwide. -X- _ O
Viral -X- _ B-Outcome
respiratory -X- _ I-Outcome
infections -X- _ I-Outcome
are -X- _ O
the -X- _ O
major -X- _ O
cause -X- _ O
of -X- _ O
acute -X- _ O
asthma -X- _ O
exacerbations -X- _ O
and -X- _ O
may -X- _ O
contribute -X- _ O
to -X- _ O
asthma -X- _ O
inception -X- _ O
in -X- _ O
high -X- _ O
risk -X- _ O
young -X- _ O
children -X- _ O
with -X- _ O
susceptible -X- _ O
genetic -X- _ O
background. -X- _ O
Acute -X- _ O
exacerbations -X- _ O
are -X- _ O
associated -X- _ O
with -X- _ O
decreased -X- _ O
lung -X- _ O
growth -X- _ O
or -X- _ O
accelerated -X- _ O
loss -X- _ O
of -X- _ O
lung -X- _ O
function -X- _ O
and -X- _ O
, -X- _ O
as -X- _ O
such -X- _ O
, -X- _ O
add -X- _ O
substantially -X- _ O
to -X- _ O
both -X- _ O
the -X- _ O
cost -X- _ O
and -X- _ O
morbidity -X- _ O
associated -X- _ O
with -X- _ O
asthma. -X- _ O
DISCUSSION -X- _ O
: -X- _ O
While -X- _ O
the -X- _ O
importance -X- _ O
of -X- _ O
preventing -X- _ O
viral -X- _ O
infection -X- _ O
is -X- _ O
well -X- _ O
established -X- _ O
, -X- _ O
preventive -X- _ O
strategies -X- _ O
have -X- _ O
not -X- _ O
been -X- _ O
well -X- _ O
explored. -X- _ O
Good -X- _ B-Outcome
personal -X- _ I-Outcome
hygiene -X- _ I-Outcome
, -X- _ I-Outcome
hand-washing -X- _ I-Outcome
and -X- _ I-Outcome
avoidance -X- _ I-Outcome
of -X- _ I-Outcome
cigarette -X- _ I-Outcome
smoke -X- _ I-Outcome
are -X- _ I-Outcome
likely -X- _ I-Outcome
to -X- _ I-Outcome
reduce -X- _ I-Outcome
respiratory -X- _ I-Outcome
viral -X- _ I-Outcome
infections. -X- _ I-Outcome
Eating -X- _ I-Outcome
a -X- _ I-Outcome
healthy -X- _ I-Outcome
balanced -X- _ I-Outcome
diet -X- _ I-Outcome
, -X- _ I-Outcome
active -X- _ I-Outcome
probiotic -X- _ I-Outcome
supplements -X- _ I-Outcome
and -X- _ I-Outcome
bacterial-derived -X- _ I-Outcome
products -X- _ I-Outcome
, -X- _ I-Outcome
such -X- _ I-Outcome
as -X- _ I-Outcome
OM-85 -X- _ I-Outcome
, -X- _ I-Outcome
may -X- _ I-Outcome
reduce -X- _ I-Outcome
recurrent -X- _ I-Outcome
infections -X- _ I-Outcome
in -X- _ I-Outcome
susceptible -X- _ I-Outcome
children. -X- _ I-Outcome
There -X- _ I-Outcome
are -X- _ I-Outcome
no -X- _ I-Outcome
practical -X- _ I-Outcome
anti-viral -X- _ I-Outcome
therapies -X- _ I-Outcome
currently -X- _ I-Outcome
available -X- _ I-Outcome
that -X- _ I-Outcome
are -X- _ I-Outcome
suitable -X- _ I-Outcome
for -X- _ I-Outcome
widespread -X- _ I-Outcome
use. -X- _ I-Outcome
SUMMARY -X- _ O
: -X- _ O
Hand -X- _ B-Outcome
hygiene -X- _ I-Outcome
is -X- _ I-Outcome
the -X- _ I-Outcome
best -X- _ I-Outcome
measure -X- _ I-Outcome
to -X- _ I-Outcome
prevent -X- _ I-Outcome
the -X- _ I-Outcome
common -X- _ I-Outcome
cold. -X- _ I-Outcome
A -X- _ I-Outcome
healthy -X- _ I-Outcome
balanced -X- _ I-Outcome
diet -X- _ I-Outcome
, -X- _ I-Outcome
active -X- _ I-Outcome
probiotic -X- _ I-Outcome
supplements -X- _ I-Outcome
and -X- _ I-Outcome
immunostimulant -X- _ I-Outcome
OM-85 -X- _ I-Outcome
may -X- _ I-Outcome
reduce -X- _ I-Outcome
recurrent -X- _ I-Outcome
infections -X- _ I-Outcome
in -X- _ I-Outcome
asthmatic -X- _ I-Outcome
children -X- _ I-Outcome
. -X- _ O

